These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3709030)

  • 1. Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion.
    Glynn AM; Slaughter RL; Brass C; D'Ambrosio R; Jusko WJ
    Clin Pharmacol Ther; 1986 Jun; 39(6):654-9. PubMed ID: 3709030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketoconazole effects on methylprednisolone disposition and their joint suppression of endogenous cortisol.
    Kandrotas RJ; Slaughter RL; Brass C; Jusko WJ
    Clin Pharmacol Ther; 1987 Oct; 42(4):465-70. PubMed ID: 3311551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid-specific effects of ketoconazole on corticosteroid disposition: unaltered prednisolone elimination.
    Ludwig EA; Slaughter RL; Savliwala M; Brass C; Jusko WJ
    DICP; 1989 Nov; 23(11):858-61. PubMed ID: 2596127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of pharmacokinetic and pharmacodynamic interactions between ketoconazole and prednisolone.
    Yamashita SK; Ludwig EA; Middleton E; Jusko WJ
    Clin Pharmacol Ther; 1991 May; 49(5):558-70. PubMed ID: 1827622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ketoconazole on methylprednisolone pharmacokinetics and receptor/gene-mediated pharmacodynamics.
    Haughey DB; Jusko WJ
    J Pharmacol Exp Ther; 1991 Nov; 259(2):826-32. PubMed ID: 1941630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ and CD8+ lymphocyte and cortisol response patterns in elderly and young males after methylprednisolone exposure.
    Tornatore KM; Venuto RC; Logue G; Davis PJ
    J Med; 1998; 29(3-4):159-83. PubMed ID: 9865456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics.
    Slayter KL; Ludwig EA; Lew KH; Middleton E; Ferry JJ; Jusko WJ
    Clin Pharmacol Ther; 1996 Mar; 59(3):312-21. PubMed ID: 8653994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortisol pharmacodynamic response to long-term methylprednisolone in renal transplant recipients.
    Tornatore KM; Reed K; Walshe JJ; Venuto RC
    Pharmacotherapy; 1994; 14(1):111-8. PubMed ID: 8159595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole decreases the clearance and enhances the effects of intravenously administered methylprednisolone in healthy volunteers.
    Varis T; Kivistö KT; Backman JT; Neuvonen PJ
    Pharmacol Toxicol; 1999 Jul; 85(1):29-32. PubMed ID: 10426160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortisol pharmacodynamics after methylprednisolone administration in young and elderly males.
    Tornatore KM; Logue G; Venuto RC; Davis PJ
    J Clin Pharmacol; 1997 Apr; 37(4):304-11. PubMed ID: 9115056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylprednisolone versus prednisolone pharmacokinetics in relation to dose in adults.
    Szefler SJ; Ebling WF; Georgitis JW; Jusko WJ
    Eur J Clin Pharmacol; 1986; 30(3):323-9. PubMed ID: 3732369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers.
    Booker BM; Magee MH; Blum RA; Lates CD; Jusko WJ
    Clin Pharmacol Ther; 2002 Oct; 72(4):370-82. PubMed ID: 12386639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.
    Fisher LE; Ludwig EA; Wald JA; Sloan RR; Middleton E; Jusko WJ
    Clin Pharmacol Ther; 1992 Jun; 51(6):677-88. PubMed ID: 1535301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylprednisolone and cortisol metabolism during the early post-renal transplant period.
    Tornatore KM; Reed KA; Venuto RC
    Clin Transplant; 1995 Dec; 9(6):427-32. PubMed ID: 8645883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling interactions between adrenal suppression and T-helper lymphocyte trafficking during multiple dosing of methylprednisolone.
    Chow FS; Sharma A; Jusko WJ
    J Pharmacokinet Biopharm; 1999 Dec; 27(6):559-75. PubMed ID: 11153446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketoconazole-induced changes in selected canine hormone concentrations.
    Willard MD; Nachreiner R; McDonald R; Roudebush P
    Am J Vet Res; 1986 Dec; 47(12):2504-9. PubMed ID: 3026211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-suppression of cortisol secretion by long term treatment with ketoconazole in patients with acute leukaemia.
    Dandona P; Mohiuddin J; Prentice HG
    J Clin Pathol; 1985 Jun; 38(6):677-8. PubMed ID: 3859494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diltiazem and mibefradil increase the plasma concentrations and greatly enhance the adrenal-suppressant effect of oral methylprednisolone.
    Varis T; Backman JT; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Mar; 67(3):215-21. PubMed ID: 10741623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cortisol and methylprednisolone secretion by the nasal mucosa].
    Houbeau C; Sulon J; Demey-Ponsart ; Mélon J
    Acta Otorhinolaryngol Belg; 1986; 40(4):582-91. PubMed ID: 3799175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ketoconazole on hepatic oxidative drug metabolism.
    Brown MW; Maldonado AL; Meredith CG; Speeg KV
    Clin Pharmacol Ther; 1985 Mar; 37(3):290-7. PubMed ID: 3971653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.